Gene · 23569
Papers4,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neutrophils as critical orchestrators of chronic inflammation. | Cell Mol Immunol | 2026 | 41530536 | PubTator, text mining | PubMed |
| Protocol for identification of protein citrullination by immunoprecipitation followed by mass spectrometry. | STAR Protoc | 2026 | 41528850 | PubTator, text mining | PubMed |
| PFKFB3-involved glycolytic metabolism supports sepsis-induced neutrophil extracellular trap formation. | Int Immunopharmacol | 2026 | 41512792 | PubTator, text mining | PubMed |
| Phytochemicals as potential inhibitors of NETosis: implications for immunothrombosis and chronic disease management. | BMC Complement Med Ther | 2026 | 41501850 | PubTator, text mining | PubMed |
| Nuclear mechanobiology rules immune cells' functions: from differentiation to cell trafficking and pathogen killing. | Nucleus | 2026 | 41495604 | PubTator, text mining | PubMed |
| PAD4+ neutrophils promote hepatic stellate cell activation and accelerate MASH fibrosis progression viaNET-DNA/TAOK1/MAPK pathways. | JCI Insight | 2026 | 41480748 | PubTator, text mining | PubMed |
| TNFAIP3, PADI4, and CXCR4 as biomarkers of neutrophil extracellular traps in severe asthma. | Int Immunopharmacol | 2026 | 41475137 | PubTator, text mining | PubMed |
| Restoring NR4A3 function in neutrophils alleviates sepsis by limiting NF-κB-dependent NETs formation and organ damage. | Mol Immunol | 2026 | 41443148 | PubTator, text mining | PubMed |
| PAD4 aggravates diabetic kidney disease by driving macrophage migration. | Mol Ther | 2026 | 41421348 | PubTator, text mining | PubMed |
| Berberine inhibits protein citrullination of fibroblast-like synoviocytes by suppressing autophagy via STAT3/PAD4 pathway. | Phytomedicine | 2026 | 41421281 | PubTator, text mining | PubMed |
| Sirtuin 2 Regulates Histone Glycation as a Semi-deglycase. | Biochemistry | 2026 | 41414978 | PubTator, text mining | PubMed |
| Targeted nuclear degranulation of neutrophils in the shock stage of severe burns drives rapid neutrophil extracellular trap release during infection to mediate acute lung injury. | Free Radic Biol Med | 2026 | 41371002 | PubTator, text mining | PubMed |
| Internally quenched fluorescent peptides provide insights into underexplored and reversible post-translational modifications. | Chem Sci | 2026 | 41358025 | PubTator, text mining | PubMed |
| Neutrophils and periodontitis: From pathological mechanisms to therapeutic opportunities. | Int Immunopharmacol | 2026 | 41325670 | PubTator, text mining | PubMed |
| Research progress on neutrophil extracellular traps and hepatitis-to-hepatocellular carcinoma transformation (Review). | Oncol Lett | 2026 | 41311814 | PubTator, text mining | PubMed |
| Circadian Control of Neutrophils Drives Collateral Perfusion and Stroke Outcome. | Circ Res | 2026 | 41293815 | PubTator, text mining | PubMed |
| Aberrant ceramide accumulation fuels eosinophilic inflammation by promoting eosinophil extracellular trap formation and release in chronic rhinosinusitis with nasal polyps. | J Allergy Clin Immunol | 2026 | 41276224 | PubTator, text mining | PubMed |
| Cholesterol Crystals and Neutrophil Extracellular Traps: Drivers of Thromboinflammation in Atherosclerosis and Gastrointestinal Cancers. | Catheter Cardiovasc Interv | 2026 | 41264766 | PubTator, text mining | PubMed |
| The neutrophil-NET Axis in ovarian cancer: Drivers of tumor microenvironment remodeling and therapeutic resistance. | Int Immunopharmacol | 2026 | 41218585 | PubTator, text mining | PubMed |
| Autoantibodies Against Type I Interferons are a Prominent Feature in SARS-CoV-2 Fatal Disease and Hospitalization. | J Infect Dis | 2026 | 41074539 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23569/papers?page=11